What is the greatest regulatory challenge in the translation of biomaterials to the clinic?
Where this comes from
- Record sourced from PubMed, PMID 23152323.
- Also identified by DOI 10.1126/scitranslmed.3004915.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.
Medical subject headings
- Animals
- Biocompatible Materials
- Biocompatible Materials/chemistry
- Biotechnology
- Biotechnology/methods
- Biotechnology/trends
- Humans
- Tissue Engineering
- Tissue Engineering/methods
- Tissue Engineering/trends
- Translational Research, Biomedical
- Translational Research, Biomedical/methods
- Translational Research, Biomedical/trends
- United States
- United States Food and Drug Administration